The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement by Carillion

18 Aug 2014 07:00

RNS Number : 3570P
Carillion PLC
18 August 2014
 



THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO UNDERTAKE ANY TRANSACTION UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT ANY TRANSACTION WILL PROCEED, OR AS TO THE TERMS OF ANY SUCH TRANSACTION.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

FOR IMMEDIATE RELEASE 18 August 2014

 

 

Statement by Carillion

 

Carillion refers to the following statement attributed to Philip Green in an article published by the Sunday Times on 17 August 2014: "Our synergy numbers have been audited, and at £1.5bn it is virtually the same as the current market value of either company." Carillion wishes to clarify that, while its previous statement that "as a direct result of the merger, the cost-base of the combined group could be reduced by at least £175 million per annum by the end of 2016"1 has not been "audited" in the technical sense, as set out in Carillion's announcement made on 14 August 2014, an independent accounting firm has provided public assurance, having tested the basis of preparation of the statement in line with the requirements of the Code, and has publicly reported that it has been properly compiled on the basis stated in that announcement. Also, Carillion's previous statement that the cost savings it has identified "would represent a capitalised value of over £1.5 billion before any re-rating"2 has not been audited or reported on by an independent accounting firm. Rather, that number was calculated on the basis set out in detail in Carillion's announcement of 14 August 2014.

 

1 Statement made on the basis of publicly available Balfour Beatty information

2 Calculated using weighted LTM multiple applied to cost-base reduction achieved by the end of 2016. See Appendix I

 

As required by Rule 2.6(a) of the Code, Carillion is required, by not later than 5.00 p.m. on 21 August 2014, to either announce a firm intention to undertake a transaction in accordance with Rule 2.7 of the Code or announce that it does not intend to undertake a transaction, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline may be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code. Carillion understands that, in accordance with Rule 2.6(c), the Takeover Panel will take into account the views of Balfour Beatty in considering whether to grant such an extension.

This announcement is not being made with the consent of Balfour Beatty.

Enquiries:

CarillionJohn Denning, Director Group Corporate Affairs +44 (0) 1902 316 426

Lazard & Co., Limited (Lead Financial Adviser) +44 (0) 20 7187 2000

Nicholas Shott

Vasco Litchfield

Cyrus Kapadia

 

Greenhill & Co. International LLP (Financial Adviser) +44 (0) 20 7198 7400

Anthony Parsons

Alex Usher-Smith

HSBC Bank plc (Financial Adviser) +44 (0) 20 7991 8888

Charles Packshaw

Morgan Stanley & Co. International plc (Joint Corporate Broker)Peter Moorhouse +44 (0) 20 7425 8000

Oriel Securities (Joint Corporate Broker)David Arch +44 (0) 20 7710 7600

Finsbury (PR Adviser)James Murgatroyd +44 (0) 20 7251 3801Gordon Simpson

Important Notices

This announcement is not intended to and does not constitute or form part of any offer to sell or subscribe for or any invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction.

Lazard & Co., Limited ("Lazard"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as lead financial adviser to Carillion plc ("Carillion") and no one else in connection with the possible transaction and will not be responsible to anyone other than Carillion for providing the protections afforded to clients of Lazard & Co., Limited nor for providing advice in relation to the possible transaction or any other matters referred to in this announcement. Neither Lazard & Co., Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard & Co., Limited in connection with this announcement, any statement contained herein, the possible transaction or otherwise.

Greenhill & Co. International LLP ("Greenhill"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser to Carillion and no one else in connection with the possible transaction and will not be responsible to anyone other than Carillion for providing the protections afforded to clients of Greenhill & Co. International LLP nor for providing advice in relation to the possible transaction or any other matters referred to in this announcement. Neither Greenhill & Co. International LLP nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Greenhill & Co. International LLP in connection with this announcement, any statement contained herein, the possible transaction or otherwise.

Morgan Stanley & Co. International plc, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting as joint corporate broker to Carillion, and no one else in connection with the matters referred to in this announcement. In connection with such matters, Morgan Stanley & Co. International plc, its affiliates and its and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person other than Carillion for providing the protections afforded to their clients or for providing advice in connection with the contents of this announcement or any other matter referred to herein.

Oriel Securities Limited, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting as joint corporate broker to Carillion, and no one else in connection with the matters referred to in this announcement. In connection with such matters, Oriel Securities Limited, its affiliates and its and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person other than Carillion for providing the protections afforded to their clients or for providing advice in connection with the contents of this announcement or any other matter referred to herein.

HSBC Bank plc ("HSBC"), which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting as financial adviser to Carillion and no one else in connection with the possible transaction and will not be responsible to anyone other than Carillion for providing the protections afforded to clients of HSBC Bank plc nor for providing advice in relation to the possible transaction or any other matters referred to in this announcement.

Cautionary Note Regarding Forward-Looking Statements

This announcement contains certain forward-looking statements with respect to the financial condition, results of operations and business of Carillion and Balfour Beatty and the combined group. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "hope", "aims", "continue", "will", "may", "should", "would", "could", or other words of similar meaning. Forward looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; (ii) business and management strategies and the expansion and growth of Carillion's or Balfour Beatty's operations and potential synergies resulting from the transaction; and (iii) the effects of government regulation on Carillion's or Balfour Beatty's business. These statements are based on assumptions and assessments made by Carillion, in light of their experience and their perception of historical trends, current conditions, future developments and other factors they believe appropriate.

By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that will occur in the future and the factors described in the context of such forward-looking statements in this document could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. They are also based upon assumptions. Many factors may cause the actual results, performance or achievements of Carillion to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Important factors that could cause actual results, performance or achievements of Carillion to differ materially from the expectations of Carillion, include, among other things, general business and economic conditions globally, industry trends, competition, changes in government and other regulation, changes in political and economic stability, disruptions in business operations due to reorganisation activities, tax rates, interest rate and currency fluctuations, the failure to satisfy any conditions for the merger on a timely basis or at all, the failure to satisfy the conditions of any merger if and when implemented (including approvals or clearances from regulatory and other agencies and bodies) on a timely basis or at all, the failure of Carillion to combine with Balfour Beatty on a timely basis or at all, the inability of the combined group to realise successfully any anticipated synergies or cost reductions if and when the merger is implemented, the inability of the combined group to integrate successfully Carillion and Balfour Beatty's operations and programmes if and when the merger is implemented, the combined group incurring and/or experiencing unanticipated costs and/or delays or difficulties relating to the merger when the merger is implemented. Such forward-looking statements should therefore be construed in light of such factors.

Neither Carillion, nor any of its associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Carillion does not assume any obligation to update or correct the information contained in this document (whether as a result of new information, future events or otherwise), except as required by applicable law.

No Profit Forecasts Or Estimates

No statement in this announcement is intended as a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per share for Carillion or the combined group, as appropriate, for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for Carillion, as appropriate.

Rounding

Certain figures included in this announcement have been subjected to rounding adjustments.

Publication On Website

A copy of this announcement will be available, subject to certain restrictions relating to persons resident in restricted jurisdictions, for inspection on Carillion's website by no later than 12 noon (London time) on the day following this announcement. For the avoidance of doubt, the contents of such website are not incorporated into and do not form part of this announcement.

THIS ANNOUNCEMENT IS NOT AN OFFER TO BUY BALFOUR BEATTY SECURITIES OR AN INVITATION TO SELL CARILLION SECURITIES IN ANY JURISDICTION. THE CARILLION SHARES ARE NOT, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933 AND MAY NOT BE OFFERED OR SOLD WITHOUT AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT OF 1933.

 

APPENDIX ISOURCES AND BASES

· Unless otherwise stated, financial and other information concerning Carillion and Balfour Beatty has been extracted from publicly available sources or from Carillion's management sources (in respect of information relating to Carillion).

· The figure set out for the capitalised value of cost savings of at least £1.5 billion is based on £175 million of cost savings taxed at the 2014 UK corporate tax rate of 21 per cent. and capitalised at the Last Twelve Month ("LTM") market capitalisation weighted price to earnings multiple of 11.7 times. The LTM price to earnings multiple for each of Balfour Beatty and Carillion is calculated by dividing their respective share prices as at close of business on 24 July 2014 (sourced from FactSet) by their respective underlying earnings per share for the 12 month period to June 2014 ("LTM underlying earnings per share"). The LTM underlying earnings per share is calculated as the sum of the underlying earnings per share in H2 2013 and H1 2014. H2 2013 underlying earnings per share is calculated as full year 2013 underlying earnings per share less H1 2013 underlying earnings per share. The underlying earnings per share information is sourced from the respective company's 2013 annual accounts and their 2013 and 2014 half year results. The implied price to earnings multiples of Balfour Beatty and Carillion are then weighted by their respective market capitalisations (as at close of business on 24 July 2014) to derive the LTM market capitalisation weighted price to earnings multiple of 11.7 times. This calculation is based on historical earnings per share in order that this statement is not construed as a profit forecast under the rules of the Code.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEVLBFZVFZBBQ
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.